Novel inhibitors of macrophage migration inhibitory factor prevent cytokine-induced beta cell death.
Eur J Pharmacol
; 740: 683-9, 2014 Oct 05.
Article
in En
| MEDLINE
| ID: mdl-24967533
ABSTRACT
Macrophage migration inhibitory factor is a multifunctional cytokine involved in the regulation of immune processes and also in apoptosis induction. Elevated MIF expression is detrimental for insulin-producing beta cells and MIF inhibition protected beta cells from several cytotoxic insults such as inflammatory cytokines, high fatty acids or high glucose concentrations. Therefore, the aim of this study was to investigate two newly synthesized small molecule MIF inhibitors (K664-1 and K647-1) and to compare them with previously established effects of the prototypical MIF inhibitor, ISO-1. Our results indicate that K664-1 and K647-1 are 160- and 40-fold more effective in inhibition of MIF׳s tautomerase activity than ISO-1. Also, new inhibitors confer beta cell protection from cytokine-triggered apoptosis at significantly lower concentrations than ISO-1. Although all three MIF inhibitors inhibit caspase 3 activity, K664-1 and K647-1 suppress pro-apoptotic BAX protein expression and up-regulate anti-apoptotic Bcl-2 mRNA. Finally, all three MIF inhibitors operate through blockade of nitric oxide production stimulated by cytokines. In conclusion, two novel MIF inhibitors are more potent than ISO-1 and operate through inhibition of the mitochondria-related apoptotic pathway. We propose that these compounds represent a unique class of anti-MIF antagonists that should be further tested for therapeutic use.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oximes
/
Catechols
/
Macrophage Migration-Inhibitory Factors
/
Intramolecular Oxidoreductases
/
Insulin-Secreting Cells
/
Heterocyclic Compounds, 2-Ring
/
Niacin
Limits:
Animals
Language:
En
Journal:
Eur J Pharmacol
Year:
2014
Document type:
Article